Clinical Trial Update: Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the combination of voriconazole and anidulafungin for invasive aspergillosis in patients unable to take polyene was terminated; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Anidulafungin (anidulafungin)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Aspergillosis | Phase 4 | Status: TERMINATED | Results posted: 2010-02-15